"We diagnose, evaluate and treat blood diseases (hematology) and cancer (oncology). Diagnosing and treating blood diseases and cancer can be a complex process. Fortunately, our team has access to a range of options from advanced diagnostic imaging to chemotherapy to support services."

During the past decade, Columbia Basin Hematology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 52 clinical trials were completed, i.e. on average, 1040% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia Basin Hematology" #1 sponsor was "SWOG Cancer Research Network" with 48 trials, followed by "National Cancer Institute (NCI)" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Celgene" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Basin Hematology" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Columbia Basin Hematology" are "Breast Cancer" (17 trials), "Lymphoma" (12 trials), "Lung Cancer" (11 trials), "Leukemia" (9 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Columbia Basin Hematology" in a lesser frequency.

Most popular intervention types in "Columbia Basin Hematology" are "Drug" (75 trials), "Biological" (23 trials), "Other" (22 trials), "Radiation" (12 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (13 trials), "doxorubicin hydrochloride" (8 trials), "radiation therapy" (8 trials), "bevacizumab" (7 trials) and "laboratory biomarker analysis" (7 trials). Other intervention names were less common.

The vast majority of trials in "Columbia Basin Hematology" are 72 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Columbia Basin Hematology". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Columbia Basin Hematology, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia Basin Hematology, 4 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".